Your browser doesn't support javascript.
loading
Loss of regulatory capacity in Treg cells following rhinovirus infection.
Jansen, Kirstin; Wirz, Oliver F; van de Veen, Willem; Tan, Ge; Mirer, David; Sokolowska, Milena; Satitsuksanoa, Pattraporn; Message, Simon D; Kebadze, Tatiana; Glanville, Nicholas; Mallia, Patrick; Skiepko, Roman; Eljaszewicz, Andrzej; Moniuszko, Marcin; Cardoso, Carlos; Gern, James E; Papadopoulos, Nikolaos G; Akdis, Cezmi A; Johnston, Sebastian L; Nadeau, Kari C; Akdis, Mübeccel.
Afiliação
  • Jansen K; Swiss Institute of Allergy and Asthma Research, University of Zurich, Davos, Switzerland.
  • Wirz OF; Swiss Institute of Allergy and Asthma Research, University of Zurich, Davos, Switzerland.
  • van de Veen W; Swiss Institute of Allergy and Asthma Research, University of Zurich, Davos, Switzerland; Christine Kühne Center for Allergy Research and Education, Davos, Switzerland.
  • Tan G; Swiss Institute of Allergy and Asthma Research, University of Zurich, Davos, Switzerland; Functional Genomics Center Zürich, ETH Zürich/University of Zürich, Zürich, Switzerland.
  • Mirer D; Swiss Institute of Allergy and Asthma Research, University of Zurich, Davos, Switzerland.
  • Sokolowska M; Swiss Institute of Allergy and Asthma Research, University of Zurich, Davos, Switzerland.
  • Satitsuksanoa P; Swiss Institute of Allergy and Asthma Research, University of Zurich, Davos, Switzerland.
  • Message SD; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Kebadze T; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Glanville N; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Mallia P; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Skiepko R; Department of Regenerative Medicine and Immune Regulation, Medical University of Bialystok, Bialystok, Poland.
  • Eljaszewicz A; Department of Regenerative Medicine and Immune Regulation, Medical University of Bialystok, Bialystok, Poland.
  • Moniuszko M; Department of Regenerative Medicine and Immune Regulation, Medical University of Bialystok, Bialystok, Poland.
  • Cardoso C; Pneumonology Department, Hochgebirgsklinik Davos, Davos, Switzerland.
  • Gern JE; Department of Pediatrics, University of Wisconsin-Madison, Madison, Wis.
  • Papadopoulos NG; Division of Infection, Immunity and Respiratory Medicine, The University of Manchester, Manchester, United Kingdom; Allergy Department, Second Pediatric Clinic, University of Athens, Athens, Greece.
  • Akdis CA; Swiss Institute of Allergy and Asthma Research, University of Zurich, Davos, Switzerland; Christine Kühne Center for Allergy Research and Education, Davos, Switzerland.
  • Johnston SL; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Nadeau KC; Sean N. Parker Center for Allergy and Asthma Research, Department of Medicine, Stanford University, Palo Alto, Calif.
  • Akdis M; Swiss Institute of Allergy and Asthma Research, University of Zurich, Davos, Switzerland. Electronic address: akdism@siaf.uzh.ch.
J Allergy Clin Immunol ; 148(4): 1016-1029.e16, 2021 10.
Article em En | MEDLINE | ID: mdl-34153372
ABSTRACT

BACKGROUND:

Respiratory infections with rhinoviruses (RV) are strongly associated with development and exacerbations of asthma, and they pose an additional health risk for subjects with allergy.

OBJECTIVE:

How RV infections and chronic allergic diseases are linked and what role RV plays in the breaking of tolerance in regulatory T (Treg) cells is unknown. Therefore, this study aims to investigate the effects of RV on Treg cells.

METHODS:

Treg cells were isolated from subjects with asthma and controls after experimental infection with the RV-A16 (RV16) and analyzed with next-generation sequencing. Additionally, suppression assays, quantitative PCR assays, and protein quantifications were performed with Treg cells after in vitro RV16 infection.

RESULTS:

RV16 induced a strong antiviral response in Treg cells from subjects with asthma and controls, including the upregulation of IFI44L, MX1, ISG15, IRF7, and STAT1. In subjects with asthma, the inflammatory response was exaggerated and showed a dysregulated immune response compared with that in the controls. Furthermore, subjects with asthma failed to upregulate several immunosuppressive molecules such as CTLA4 and CD69, and they upregulated the inflammasome-related genes PYCARD and AIM2. Additionally, RV16 reduced the suppressive capacity of Treg cells from healthy subjects and subjects with asthma in vitro and increased TH2 cell-type cytokine production.

CONCLUSIONS:

Treg cells from healthy subjects and subjects with asthma displayed an antiviral response after RV infection and showed reduced suppressive capacity. These data suggest that Treg cell function might be altered or impaired during RV infections, which might play an important role in the association between RV and the development of asthma and asthma exacerbations.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Rhinovirus / Linfócitos T Reguladores / Infecções por Picornaviridae Limite: Adolescent / Adult / Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Rhinovirus / Linfócitos T Reguladores / Infecções por Picornaviridae Limite: Adolescent / Adult / Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article